In addition, therapeutic effects of ucOCN in NAFLD mice may be intervened by activating the nuclear factor like-2 (Nrf2) pathway to alleviate oxidative stress and to inhibit the JNK pathway in hepatocytes (Du et al., 2016). This evidence concerns the gene MAPK8 and metabolic dysfunction-associated steatotic liver disease.